The interactive effects of ketamine and magnesium upon depressive-like pathology

Código QR

The interactive effects of ketamine and magnesium upon depressive-like pathology

Sara Razmjou, Darcy Litteljohn, Chris Rudyk, Shuaib Syed, Melanie Clarke, Rowan Pentz, Zach Dwyer, Shawn Hayley Department of Neuroscience, Carleton University, Ottawa, Ontario, Canada Abstract: Approximately one-third of patients with major depressive disorders (MDDs) are resistant to current tre...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Razmjou S, Litteljohn D, Rudyk C, Syed S, Clarke M, Pentz R, Dwyer Z, Hayley S
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	depression ketamine magnesium treatment resistant Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/c42b095f923341df93ba59074273d612
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Case Report: Repeated Series of Ketamine Infusions in Patients With Treatment-Resistant Depression: Presentation of Five Cases
por: Maria Gałuszko-Wȩgielnik, et al.
Publicado: (2021)

The effects of nebulized ketamine and intravenous magnesium sulfate on corticosteroid resistant asthma exacerbation; a randomized clinical trial
por: Kimia Farshadfar, et al.
Publicado: (2021)

Involvement of serotonergic, noradrenergic and gabaergic systems in the antinociceptive effect of a ketamine-magnesium sulfate combination in acute pain
por: Katarina Savić Vujović, et al.
Publicado: (2018)

Novel Insights Into the Neurobiology of the Antidepressant Response From Ketamine Research: A Mini Review
por: Michael Colla, et al.
Publicado: (2021)

Ketamine—New Possibilities in the Treatment of Depression: A Narrative Review
por: Mateusz Kowalczyk, et al.
Publicado: (2021)

Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
por: Wei Zheng, et al.
Publicado: (2021)

Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression
por: Szarmach J, et al.
Publicado: (2020)

Immunoregulation and antidepressant effect of ketamine
por: Zhang Nan, et al.
Publicado: (2021)

An Integrative Approach to Ketamine Therapy May Enhance Multiple Dimensions of Efficacy: Improving Therapeutic Outcomes With Treatment Resistant Depression
por: Sherry-Anne Muscat, et al.
Publicado: (2021)

EFFECT OF SINGLE DOSE OF KETAMINE IN PATIENTS OF MAJOR DEPRESSIVE DISORDER-A PAKISTANI PERSPECTIVE
por: Muhammad Siddique Kakar, et al.
Publicado: (2020)

Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study
por: Wilkowska A, et al.
Publicado: (2021)

Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency
por: Naghmeh Nikkheslat
Publicado: (2021)

Effect of Ketamine in the Treatment of Patients with Major Depressive Disorder
por: F Kheirkhah, et al.
Publicado: (2010)

BDNF and the Antidepressant Effects of Ketamine and Propofol in Electroconvulsive Therapy: A Preliminary Study
por: Huang XB, et al.
Publicado: (2020)

Case Report: Unexpected Remission From Extreme and Enduring Bulimia Nervosa With Repeated Ketamine Assisted Psychotherapy
por: Anya Ragnhildstveit, et al.
Publicado: (2021)

Ketamine in Bipolar Disorder: A Review
por: Wilkowska A, et al.
Publicado: (2020)

A review of ketamine’s role in ECT and non-ECT settings
por: Jankauskas V, et al.
Publicado: (2018)

Betaine prevents and reverses the behavioral deficits and synaptic dysfunction induced by repeated ketamine exposure in mice
por: Shao-Tsu Chen, et al.
Publicado: (2021)

Addictive potential of novel treatments for refractory depression and anxiety
por: Kolar D
Publicado: (2018)

Combination of antiseizure medications phenobarbital, ketamine, and midazolam reduces soman‐induced epileptogenesis and brain pathology in rats
por: Lucille A. Lumley, et al.
Publicado: (2021)

Rapid infusion of esketamine for unipolar and bipolar depression: a retrospective chart review
por: Correia-Melo FS, et al.
Publicado: (2017)

Mania following ketamine abuse
por: Lu YY, et al.
Publicado: (2016)

Procedural moderate sedation with ketamine in pediatric critical care unit
por: Tarek R Hazwani, et al.
Publicado: (2017)

Dexmedetomidine for the management of postictal agitation after electroconvulsive therapy with S-ketamine anesthesia
por: Aksay SS, et al.
Publicado: (2017)

The place of S-ketamine in fibromyalgia treatment (ESKEFIB): study protocol for a prospective, single-center, double-blind, randomized, parallel-group, dose-escalation controlled trial
por: Zuzana Javorcikova, et al.
Publicado: (2021)

ROLE OF KETAMINE IN SUBANESTHETIC DOSE TO ALLEVIATE PROPOFOL INJECTION PAIN IN PATIENTS UNDERGOING CESAREAN SECTION SURGERY
por: Muhammad Usman Mohsin, et al.
Publicado: (2018)

Ketamine versus Dexmedetomidine in Local Wound Infiltration for Postoperative Pain Relief in Cesarean Section
por: Nourhan R. Biomy, et al.
Publicado: (2021)

Modulation of the activity of N-methyl-D-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13)
por: Vasilescu AN, et al.
Publicado: (2017)

Treatment Of Magnesium-L-Threonate Elevates The Magnesium Level In The Cerebrospinal Fluid And Attenuates Motor Deficits And Dopamine Neuron Loss In A Mouse Model Of Parkinson’s disease
por: Shen Y, et al.
Publicado: (2019)

The interactive effects of ketamine and ethanol on dopamine expression in the ventral tegmental area of rats
por: Zhang ZB, et al.
Publicado: (2018)

Are 24-hour motor activity patterns associated with continued rapid response to ketamine?
por: Duncan Jr WC, et al.
Publicado: (2018)

Correcting magnesium deficiencies may prolong life
por: Rowe WJ
Publicado: (2012)

Magnesium parameters and their association with lipid metabolism markers in obese women
por: Santos,Loanne Rocha dos, et al.
Publicado: (2021)

Vitamin D, Magnesium and Their Interactions: A Review
por: Zeinab Shahsavani, et al.
Publicado: (2021)

Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review
por: Johanna Louise Keeler, et al.
Publicado: (2021)

Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis
por: Mederle OA, et al.
Publicado: (2018)

COMPARISON OF THE EFFECT OF INTRA-CUFF KETAMINE VERSUS ALKALINIZED LIDOCAINE FOR PREVENTION OF POST-OPERATIVE SORE THROAT
por: Nadeem Naqvi, et al.
Publicado: (2021)

Effect of Dapagliflozin and Magnesium Supplementation on Renal Magnesium Handling and Magnesium Homeostasis in Metabolic Syndrome
por: Hwee-Yeong Ng, et al.
Publicado: (2021)

Magnesium deficiency and increased inflammation: current perspectives
por: Nielsen FH
Publicado: (2018)

Attenuated dopamine signaling after aversive learning is restored by ketamine to rescue escape actions
por: Mingzheng Wu, et al.
Publicado: (2021)